CD133 expression has also been reported in other sarcomas [35, 37], and correlated with lung metastases and poor prognosis in osteosarcoma [82], and poor survival in embryonal rhabdomyosarcoma [11]. The gene discussed is PROM1; the disease is osteosarcoma.